In re-examining condom labeling as directed by Public Law 106-554, FDA identified developments in the scientific research that would justify updating the labeling for latex condoms to ensure the labeling
provided the most accurate information possible. This guidance document lists the issues requiring special controls identified by FDA and describe labeling measures that, if followed by manufacturers,
will generally address the issues requiring special controls associated with latex condoms.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.